Smith Cameron, Ziogaite Monika, Doolan-Mattice Lindsay, VonHegel Heather, Akhtar Mariam, Beyersdorfer Nova, Johnson Kerry, Paulson John
Medicine, Kansas City University, Joplin, USA.
Primary Care, Kansas City University, Joplin, USA.
Cureus. 2024 Dec 31;16(12):e76693. doi: 10.7759/cureus.76693. eCollection 2024 Dec.
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease. In this study, we aimed to explore the effects of COPD and pneumonia on the mortality rates among patients admitted to the Freeman Health System in Southwest Missouri, to provide a better idea of whether there is a correlation between the two and whether the presence of both adds to the mortality rates. Patient data were extracted from electronic medical records, focusing on patients with or without COPD and pneumonia diagnoses. Analyses revealed a statistical difference, with a p-value of <0.0001, in mortality rates between COPD patients with (P1) and without (P3) pneumonia, indicating that pneumonia did have an impact on COPD patients. However, pneumonia patients without COPD (P2) had a higher, but non-statistical difference in mortality rates compared to COPD patients with pneumonia (P1), with a p-value of 0.0806. These findings emphasize the severe influence of pneumonia in both COPD and non-COPD populations in the area, warranting further investigation and emphasizing the importance of timely and appropriate treatment. These results provide insights into the interplay between COPD and pneumonia in the geographic area, which may provide guidance in treatment decisions that may improve patient outcomes.
慢性阻塞性肺疾病（COPD）是一种进行性肺部疾病。在本研究中，我们旨在探讨慢性阻塞性肺疾病和肺炎对密苏里州西南部弗里曼医疗系统收治患者死亡率的影响，以更好地了解两者之间是否存在关联，以及两者并存是否会增加死亡率。患者数据从电子病历中提取，重点关注有或无慢性阻塞性肺疾病和肺炎诊断的患者。分析显示，患有肺炎（P1）和未患有肺炎（P3）的慢性阻塞性肺疾病患者之间的死亡率存在统计学差异，p值<0.0001，这表明肺炎确实对慢性阻塞性肺疾病患者有影响。然而，未患有慢性阻塞性肺疾病的肺炎患者（P2）与患有肺炎的慢性阻塞性肺疾病患者（P1）相比，死亡率更高，但无统计学差异，p值为0.0806。这些发现强调了肺炎对该地区慢性阻塞性肺疾病和非慢性阻塞性肺疾病人群的严重影响，值得进一步研究，并强调了及时和适当治疗的重要性。这些结果为该地理区域慢性阻塞性肺疾病和肺炎之间的相互作用提供了见解，这可能为改善患者预后的治疗决策提供指导。
